R&D channel feed – Endpoints News

R&D channel feed

Sun Pharma buys out Concert, and its alopecia drug, for $576M

3 years ago

Horizon claims mid-stage victory in rare disease, lines up PhIII for new owners at Amgen

3 years ago

Ipsen has go/no-go decision to make after biotech partner's Parkinson's drug flunks PhIIb

3 years ago

Don't pack your sunglasses: No plans to move JP Morgan conference, bank says

3 years ago

Drugmakers seek tweaks to FDA guidance on measuring development in pediatric trials

3 years ago

J&J reports second HIV vaccine regimen failure in 18 months

3 years ago

With CEO search, PhIII study underway, Fulcrum Therapeutics raises $125M from stock offering

3 years ago

Gene therapy side effects prompt search for new delivery methods

3 years ago

Moderna jumps into pivotal pack with promising RSV data as big rivals face off in megablockbuster race

3 years ago

NewAmsterdam notches another win in resurrection of Amgen cardio drug

3 years ago

In ‘clever’ experiment, scientists use gene editing to treat heart disease in mice

3 years ago

Oramed’s insulin pill fails PhIII trial in diabetes, stock craters

3 years ago

Experts talk IRA impacts as CMS announces it will publish first 10 drugs up for negotiation in September

3 years ago

Sanofi extends commitment to $750M biotech startup fund

3 years ago

As Illumina disappoints Wall Street, competitors make their case at JPM

3 years ago

Flame Biosciences searches for future after Novartis flunks on canakinumab

3 years ago

Updated: Roche, Ionis launch new Huntington’s disease study

3 years ago

Arrowhead, Takeda liver drug headed to PhIII despite placebo response's dent on stock

3 years ago

Arvinas reports delay for Pfizer-partnered protein degradation program

3 years ago

FDA puts Vertex’s new Type 1 diabetes cell therapy IND on hold; Insilico sets up for PhII of AI drug

3 years ago

4D Molecular pauses enrollment in Fabry trials after kidney problems in three patients

3 years ago

MarketingRx roundup: Bluebird bio promotes sickle cell awareness; Pfizer, BioNTech encourage boosters in South

3 years ago

Jasper scraps pivotal plans but adds a new indication as more biotechs revise pipelines

3 years ago

Sutro shells out latest update on ovarian cancer treatment, plans for pivotal trial

3 years ago

First page Previous page 100 101 102103104 105 106 Next page Last page